1. Home
  2. MATW vs DRUG Comparison

MATW vs DRUG Comparison

Compare MATW & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MATW

Matthews International Corporation

HOLD

Current Price

$25.35

Market Cap

824.4M

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$74.76

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
DRUG
Founded
1850
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Pharmaceuticals and Biotechnology
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
824.4M
707.1M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
MATW
DRUG
Price
$25.35
$74.76
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$129.25
AVG Volume (30 Days)
222.9K
255.8K
Earning Date
04-30-2026
05-15-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
N/A
EPS
0.69
N/A
Revenue
$1,795,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.76
$23.18
52 Week High
$30.93
$123.75

Technical Indicators

Market Signals
Indicator
MATW
DRUG
Relative Strength Index (RSI) 34.93 37.08
Support Level $25.38 $70.35
Resistance Level $26.34 $77.01
Average True Range (ATR) 0.78 5.15
MACD -0.21 -1.01
Stochastic Oscillator 14.80 8.31

Price Performance

Historical Comparison
MATW
DRUG

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: